Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
7.64%
End price
19.03.26
€7.33
Summary
This prediction ended on 19.03.26 with a price of €7.33. With a performance of 7.64%, the BUY prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc. closed with a slight gain. Royal_Bank_of_Canada has a follow-up prediction for Ocular Therapeutix Inc. where he still thinks Ocular Therapeutix Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocular Therapeutix Inc. | -3.036% | -3.036% | 3.558% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
In the thread Trading Ocular Therapeutix Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten